We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
PTC Therapeutics
PTCT
$6.26B
| $2.24M | 0.02% |
47,945
-4,451
| -8% | -$219K |
|
|
QADA
502
DELISTED
QAD Inc.
QADA
| $2.24M | 0.02% |
53,077
-3,593
| -6% | -$151K |
|
|
PRAH
503
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.19M | 0.02% |
21,589
+2,209
| +11% | +$225K |
|
504
Insulet
PODD
$11.5B
| $2.17M | 0.02% |
9,183
+943
| +11% | +$199K |
|
505
Dana Inc
DAN
$2.91B
| $2.14M | 0.02% |
173,652
+65,709
| +61% | +$854K |
|
506
Equinix
EQIX
$103B
| $2.13M | 0.02% |
+2,804
| New | +$2.12M |
|
507
Alpha and Omega Semiconductor
AOSL
$931M
| $2.13M | 0.02% |
166,010
-8,692
| -5% | -$105K |
|
508
QCR Holdings
QCRH
$1.69B
| $2.13M | 0.02% |
77,636
-6,015
| -7% | -$177K |
|
509
AngioDynamics
ANGO
$610M
| $2.12M | 0.02% |
+175,577
| New | +$1.67M |
|
510
First Bancorp
FBNC
$2.61B
| $2.11M | 0.02% |
100,707
-10,830
| -10% | -$232K |
|
511
HUB Group
HUBG
$2.78B
| $2.09M | 0.02% |
83,224
-2,066
| -2% | -$53.5K |
|
|
CPLG
512
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $2.09M | 0.02% |
383,005
+10,442
| +3% | +$55.3K |
|
513
HubSpot
HUBS
$11.9B
| $2.09M | 0.02% |
7,138
-206
| -3% | -$54K |
|
514
Idacorp
IDA
$7.86B
| $2.08M | 0.02% |
26,038
-1,413
| -5% | -$124K |
|
515
Nicolet Bankshares
NIC
$3.57B
| $2.08M | 0.02% |
38,093
-3,244
| -8% | -$185K |
|
|
THS
516
DELISTED
Treehouse Foods
THS
| $2.07M | 0.02% |
51,057
-34,896
| -41% | -$1.48M |
|
517
Donnelley Financial Solutions
DFIN
$1.17B
| $2.05M | 0.02% |
153,632
-22,029
| -13% | -$228K |
|
|
RUBY
518
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2.02M | 0.02% |
402,555
+30,690
| +8% | +$163K |
|
519
Adaptive Biotechnologies
ADPT
$3.87B
| $2.02M | 0.02% |
41,462
+15,764
| +61% | +$663K |
|
|
SNCR
520
DELISTED
Synchronoss Technologies
SNCR
| $2.01M | 0.02% |
74,067
-1,010
| -1% | -$33.5K |
|
521
Envista
NVST
$4.52B
| $2M | 0.02% |
80,966
-179,750
| -69% | -$4.14M |
|
522
Comscore
SCOR
$112M
| $1.96M | 0.02% |
48,056
-8,863
| -16% | -$492K |
|
|
TCDA
523
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.95M | 0.02% |
215,175
+31,088
| +17% | +$454K |
|
|
TPIC
524
DELISTED
TPI Composites
TPIC
| $1.95M | 0.02% |
67,226
-256,537
| -79% | -$7.2M |
|
|
AVTA
525
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.94M | 0.02% |
206,169
+172,246
| +508% | +$1.91M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.